Cetera Investment Advisers Acquires 5,712 Shares of Astera Labs, Inc. $ALAB

Cetera Investment Advisers lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 167.1% in the 2nd quarter, Holdings Channel reports. The firm owned 9,131 shares of the company’s stock after buying an additional 5,712 shares during the quarter. Cetera Investment Advisers’ holdings in Astera Labs were worth $826,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company’s stock valued at $554,780,000 after buying an additional 85,846 shares in the last quarter. Alliancebernstein L.P. raised its stake in shares of Astera Labs by 114.2% in the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after acquiring an additional 4,478,741 shares in the last quarter. Atreides Management LP lifted its holdings in Astera Labs by 153.3% in the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock worth $277,601,000 after purchasing an additional 2,815,614 shares during the last quarter. Fred Alger Management LLC boosted its position in Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after purchasing an additional 179,638 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Astera Labs by 36.2% during the second quarter. Geode Capital Management LLC now owns 1,244,978 shares of the company’s stock valued at $112,562,000 after purchasing an additional 330,841 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 150,000 shares of the stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the transaction, the director owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This represents a 8.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the transaction, the chief operating officer owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This represents a 5.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 586,936 shares of company stock worth $89,331,140 in the last ninety days. Company insiders own 12.50% of the company’s stock.

Astera Labs Stock Up 5.7%

ALAB stock opened at $161.23 on Friday. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90. The company has a market cap of $27.23 billion, a PE ratio of 145.25, a price-to-earnings-growth ratio of 2.84 and a beta of 1.51. The business’s 50-day simple moving average is $170.02 and its 200 day simple moving average is $150.72.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The company had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. During the same quarter last year, the company earned $0.23 EPS. The company’s quarterly revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on ALAB. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research note on Wednesday. Stifel Nicolaus lifted their target price on shares of Astera Labs from $185.00 to $200.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Barclays reissued an “equal weight” rating and set a $155.00 target price on shares of Astera Labs in a research report on Monday, October 20th. BNP Paribas assumed coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $160.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, September 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $187.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.